Reporting owner · CIK 0001589776
Brughera Marco Maria
SEC Form 4 history across 1 companies, 3 transactions and 1 filings.
DIRFENNEC PHARMACEUTICALS INC.
Open-market transaction mix0% buys0 buys · 1 sales
Available history · Sep 15, 2026 – Sep 15, 2026
Latest insider transactions
Form 4 filings from available history.| Company | Insider | Activity | Disclosed value | Filed (ET) |
|---|---|---|---|---|
FENCFENNEC PHARMACEUTICALS INC. | Brughera Marco MariaDIR | M · exercise10b5-1 detectedDerivative securitySEC filing ↗ | $0View disclosure → | |
FENCFENNEC PHARMACEUTICALS INC. | Brughera Marco MariaDIR | S · sale10b5-1 detectedSEC filing ↗ | -$159kView disclosure → | |
FENCFENNEC PHARMACEUTICALS INC. | Brughera Marco MariaDIR | M · exercise10b5-1 detectedSEC filing ↗ | $32.7kView disclosure → |
Latest Form 4 facts
Quick context from source filings
Latest open-market transaction
sale at FENNEC PHARMACEUTICALS INC. on Sep 15, 2026 valued at $159,958.
Review SEC filingLatest buy
No open-market insider purchase is available.
Monthly open-market activity
Last 1 reported months · purchases and sales
View exact monthly values
| Month | Purchases | Sales | Buy value | Sale value | Net value |
|---|---|---|---|---|---|
| Sep 2026 | 0 | 1 | $0.00 | $159,958.05 | -$159,958.05 |
Net value is disclosed purchases minus sales, not profit. A dash means the value is unavailable.
Ownership and transaction size
Ownership and ticket size
Average P/S size$160K
Median P/S size$160K
Direct3
Indirect0
Sep 15, 2026exercise
Filing-only signals
Deterministic matches in this insider's history
No filing-only signal badges matched this history.
Associated companies
Companies in the disclosed reporting history
Open-market buy performance
90-day forward return on this insider's open-market purchases
No open-market purchases in available history
A 90-day purchase return requires an open-market buy. No eligible purchases are recorded in this history.
Disclosed ownership
How reported shareholdings evolved
Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.
2 observations · Sep 15, 2026 – Sep 15, 2026. Window ends at the latest available report, not today.
Selected observation · Sep 15, 20260 shares reported
Inspect transaction View exact observations and source transactions
| Transaction date | Shares held after | Filed | Source |
|---|---|---|---|
| Sep 15, 2026 | 15,545 | Sep 16, 2026 | View transaction |
| Sep 15, 2026 | 0 | Sep 16, 2026 | View transaction |
Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.
Brughera Marco Maria Insider Activity FAQ
SEC Form 4 context
Who is Brughera Marco Maria?
Brughera Marco Maria is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001589776.
Which companies has Brughera Marco Maria reported transactions for?
FENNEC PHARMACEUTICALS INC.
When was Brughera Marco Maria's latest insider buy?
No open-market insider purchase is available for this period.
When was Brughera Marco Maria's latest insider sale?
sale at FENNEC PHARMACEUTICALS INC. on Sep 15, 2026 valued at $159,958.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
The profile shows average and median 90-day stock returns after open-market purchases when price coverage is available. These are unadjusted stock returns, not realized trading gains. Win rates, benchmark-adjusted returns and conviction scores are not calculated.